Episode Details

Back to Episodes
Dr. Bob Rowland: Genetic Strategies for Disease Resistance | Ep. 163

Dr. Bob Rowland: Genetic Strategies for Disease Resistance | Ep. 163

Season 2 Episode 163 Published 8ย months ago
Description

In this episode of the Swine Health Blackbelt Podcast, Dr. Bob Rowland from the University of Illinois shares key insights on the genetics behind PRRS resilience in pigs. He discusses the development of CD163-edited pigs and how understanding virus-host interactions can support future strategies. Discover how genome research is contributing to swine health innovation. Listen now on all major platforms!


"We all know that CD163 is the receptor for PRRS, and when we knocked it out, the pigs were completely resistantโ€”no infection, no antibodies, no virus replication."


๐— ๐—ฒ๐—ฒ๐˜ ๐˜๐—ต๐—ฒ ๐—ด๐˜‚๐—ฒ๐˜€๐˜: Dr. Bob Rowland is Professor and Head of the Department of Pathobiology at the University of Illinois College of Veterinary Medicine. He holds a Ph.D. and has led major research on genetic resistance to PRRSV, PCV, and ASFV. With over 160 publications, he brings vast expertise in virus-host interaction and genome editing in pigs.


Liked this one? Donโ€™t stop now โ€” Hereโ€™s what we think youโ€™ll love!


What you will learn:

  • (00:00) Highlight
  • (01:01) Introduction
  • (02:23) Genetic PRRS resistance
  • (05:17) CD163-edited pigs
  • (07:06) Genome editing impact
  • (08:05) Stress and inflammation
  • (09:08) Future disease targets
  • (12:36) Closing thoughts


The Swine Health Blackbelt Podcast is trusted and supported by innovative companies like:


*ย Boehringer Ingelheim

-ย Farm Health Guardian


๐—Ÿ๐—ถ๐˜€๐˜๐—ฒ๐—ป ๐—ผ๐—ป ๐—”๐—ฝ๐—ฝ๐—น๐—ฒ ๐—ฃ๐—ผ๐—ฑ๐—ฐ๐—ฎ๐˜€๐˜๐˜€, ๐—ฆ๐—ฝ๐—ผ๐˜๐—ถ๐—ณ๐˜† ๐—ผ๐—ฟ ๐—ฎ๐—ป๐˜† ๐—บ๐—ฎ๐—ท๐—ผ๐—ฟ ๐—ฝ๐—น๐—ฎ๐˜๐—ณ๐—ผ๐—ฟ๐—บ.

Website:ย The Swine Health Blackbelt Podcast

Instagram:ย Swine Campus

LinkedIn:ย Swine Campus

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us